Jean‐Louis Junien

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

Sven Francque, Pierre Bédossa, Vlad Ratziu et al. · New England Journal of Medicine · 2021 · 655 citations · Full text

N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors

François P. Monnet, Guy Debonnel, Jean‐Louis Junien et al. · European Journal of Pharmacology · 1990 · 229 citations

Synaptic Plasticity, Molecular Neuroscience, Synaptic Signaling +9

Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures

Pierre Broqua, Joseph G. Wettstein, M.N. Rocher et al. · Behavioural Pharmacology · 1995 · 197 citations

Chronic Inhibition of Circulating Dipeptidyl Peptidase IV by FE 999011 Delays the Occurrence of Diabetes in Male Zucker Diabetic Fatty Rats

Béatrice Sudre, Pierre Broqua, Richard White et al. · Diabetes · 2002 · 167 citations · Full text

Glucose Tolerance, Insulin Signaling, Gastrointestinal Peptide Hormone +17

Pharmacological Profile of a New, Potent, and Long-Acting Gonadotropin-Releasing Hormone Antagonist: Degarelix

Pierre Broqua, Pierre Rivière, P. Michael Conn et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 150 citations